Literature DB >> 9120726

Angiogenesis and inflammation in ductal carcinoma in situ of the breast.

A H Lee1, L C Happerfield, L G Bobrow, R R Millis.   

Abstract

Several recent studies suggest that vascular density may be an independent prognostic indicator in invasive carcinoma of the breast. Increased vascularity has also been shown in ductal carcinoma in situ (DCIS). The prognostic significance of the inflammatory infiltrate in mammary carcinoma is more controversial, but it could affect angiogenesis by releasing angiogenic factors and digesting matrix. Vascularity and inflammation have been studied in 41 examples of pure DCIS, classified using the method of Holland et al. Immunohistochemistry was performed with antibodies to von Willebrand factor, CD3, CD8, CD45RO, CD45RA, CD20, CD68, and c-erB-2. The main pattern of inflammation was clusters of B and T cells situated either adjacent to involved ducts or in the interductal stroma. Typically, these clusters were around vessels with plump endothelium suggestive of high endothelial venules. A less prominent pattern was a diffuse stromal infiltrate of macrophages and T cells. There were two patterns of increased vascularity associated with DCIS: necklaces of vessels close to the involved ducts and vessels arranged diffusely in the interductal stroma. Each pattern of inflammation and of vascularity was graded semi-quantitatively. Increased stromal vascularity was associated with the perivascular clusters of inflammation; both were associated with c-erB-2 expression and extent of the DCIS. Necklaces of vessels were associated with the diffuse inflammation. Perivascular inflammation and c-erB-2 (but neither pattern of vascularity) were associated with poor differentiation of the DCIS. Thus, different patterns of inflammation are associated with different patterns of vessels. The clusters of B and T cells may be recruited via high endothelial venules induced by the DCIS. Cytokines released by the DCIS and/or the inflammatory cells (clusters or diffuse) may stimulate the two patterns of new vessel formation.

Entities:  

Mesh:

Year:  1997        PMID: 9120726     DOI: 10.1002/(SICI)1096-9896(199702)181:2<200::AID-PATH726>3.0.CO;2-K

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  16 in total

1.  Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.

Authors:  A J Rice; M A Steward; C M Quinn
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

Review 2.  Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast.

Authors:  A Rice; C M Quinn
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

3.  Angiogenesis and inflammation in invasive carcinoma of the breast.

Authors:  A H Lee; L C Happerfield; L G Bobrow; R R Millis
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

4.  Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.

Authors:  Michael J Campbell; Frederick Baehner; Tess O'Meara; Ekene Ojukwu; Booyeon Han; Rita Mukhtar; Vickram Tandon; Max Endicott; Zelos Zhu; Jasmine Wong; Gregor Krings; Alfred Au; Joe W Gray; Laura Esserman
Journal:  Breast Cancer Res Treat       Date:  2016-10-26       Impact factor: 4.872

5.  Ductal carcinoma in situ of the breast: immune cell composition according to subtype.

Authors:  Marie Colombe Agahozo; Mieke R van Bockstal; Floris H Groenendijk; Thierry P P van den Bosch; Pieter J Westenend; Carolien H M van Deurzen
Journal:  Mod Pathol       Date:  2019-08-02       Impact factor: 7.842

6.  TGF-β1 precursor and CD8 are potential prognostic and predictive markers in operated breast cancer.

Authors:  Hai-Ming Yu; Jun-Lan Yang; Shun-Chang Jiao; Jian-Dong Wang; Ying Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-02-06

7.  The immune microenvironment of breast ductal carcinoma in situ.

Authors:  Elizabeth Thompson; Janis M Taube; Hillary Elwood; Rajni Sharma; Alan Meeker; Hind Nassar Warzecha; Pedram Argani; Ashley Cimino-Mathews; Leisha A Emens
Journal:  Mod Pathol       Date:  2016-01-15       Impact factor: 7.842

8.  Tumor angiogenesis as a target for dietary cancer prevention.

Authors:  William W Li; Vincent W Li; Michelle Hutnik; Albert S Chiou
Journal:  J Oncol       Date:  2011-09-29       Impact factor: 4.375

9.  Elevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease.

Authors:  J A Foekens; Ch Ries; M P Look; C Gippner-Steppert; J G M Klijn; M Jochum
Journal:  Br J Cancer       Date:  2003-04-07       Impact factor: 7.640

Review 10.  Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.

Authors:  David G DeNardo; Lisa M Coussens
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.